Global Combined Polio Vaccine Supply, Demand and Key Producers, 2026-2032
The global Combined Polio Vaccine market size is expected to reach $ 6550 million by 2032, rising at a market growth of 6.0% CAGR during the forecast period (2026-2032).
Combined polio vaccine refers to a preventive biological product that contains an inactivated polio vaccine component and is combined with other pediatric immunization antigens such as diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, or other routine childhood vaccine components in the same formulation or immunization program. Its core value lies in providing ?multiple protection in one injection? or ?broader protection with fewer injections,? while maintaining immunogenicity and safety. It helps reduce the number of pediatric injections, ease vaccination clinic workload, improve parental compliance, and enhance the execution efficiency of immunization programs. Compared with standalone polio vaccines, combined polio vaccines not only serve the public health function of preventing poliomyelitis, but also represent the transition of pediatric vaccines from single-antigen products toward combination, premium, convenient, and systematic immunization management, making them a key reflection of a vaccine company?s technology platform, quality system, and market competitiveness.In 2025, global Combined polio vaccine production reached approximately 42 million units.The average gross profit margin of this product is 85%.
The market opportunities for combined polio vaccines come from immunization strategy upgrading in the post-oral live attenuated vaccine era, rising demand for more convenient pediatric vaccination, and the value release of premium combination vaccine platforms. As global polio eradication enters its late stage, immunization strategies containing IPV components are becoming increasingly important for safety, long-term protection, and sustainable supply. China has optimized its routine polio immunization schedule, reflecting the national immunization system?s recognition of the foundational role of inactivated polio vaccines. Combination vaccines further integrate polio protection with pediatric immunization needs such as diphtheria, tetanus, pertussis, and Hib, transforming the product from a single public health vaccine into a high-value pediatric immunization solution. For manufacturers, combined polio vaccines can extend product life cycles, strengthen brand barriers, and drive upgrades in registration, production, cold chain, terminal education, and international cooperation capabilities.
The biggest challenges in this industry lie in multi-antigen compatibility, clinical validation, quality consistency, and regulatory barriers. A combination vaccine is not simply the mixing of several antigens; it must balance antigen compatibility, adjuvant systems, stability, immune interference, batch consistency, and safety monitoring. IPV-containing combination vaccines also involve virus culture, inactivation validation, antigen quantification, and biosafety control, making production significantly more complex than ordinary monovalent vaccines. Because pediatric vaccines are administered to infants and young children, regulators, disease control systems, and parents have extremely high expectations for product quality, adverse event monitoring, supply stability, and brand credibility. At the same time, pricing systems, regional procurement cycles, competitive substitution, reimbursement environments, and changes in vaccination willingness may affect commercialization progress and profitability flexibility.
Downstream demand is evolving from ?completing scheduled vaccination? toward pediatric immunization management with fewer injections, higher efficiency, and better user experience. Disease control institutions and vaccination clinics hope that combination vaccines can reduce queuing pressure, lower missed-dose risk, simplify vaccination procedures, and improve service efficiency. Parents care more about reducing children?s pain, making vaccination schedules clearer, and choosing products with stronger safety credibility. Medical institutions and private vaccination sites place greater value on premium vaccine combinations, differentiated services, and brand recognition. As young families become more aware of preventive medicine, acceptance of combination vaccines is expected to continue improving. In the future, IPV-containing multivalent vaccines will gradually move from supplementary options in basic immunization toward an important direction for premium, convenient, and branded pediatric vaccination.
This report studies the global Combined Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Combined Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Combined Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Combined Polio Vaccine total production and demand, 2021-2032, (K Units)
Global Combined Polio Vaccine total production value, 2021-2032, (USD Million)
Global Combined Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Combined Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Combined Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Combined Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Combined Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Combined Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Combined Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Viatris, Pfizer, Sanofi, BD, Eli Lilly, Gerresheimer, Dongbao, Ypsomed, Owen Mumford, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Combined Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Combined Polio Vaccine Market, By Region:
1. How big is the global Combined Polio Vaccine market?
2. What is the demand of the global Combined Polio Vaccine market?
3. What is the year over year growth of the global Combined Polio Vaccine market?
4. What is the production and production value of the global Combined Polio Vaccine market?
5. Who are the key producers in the global Combined Polio Vaccine market?
6. What are the growth factors driving the market demand?
Combined polio vaccine refers to a preventive biological product that contains an inactivated polio vaccine component and is combined with other pediatric immunization antigens such as diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, or other routine childhood vaccine components in the same formulation or immunization program. Its core value lies in providing ?multiple protection in one injection? or ?broader protection with fewer injections,? while maintaining immunogenicity and safety. It helps reduce the number of pediatric injections, ease vaccination clinic workload, improve parental compliance, and enhance the execution efficiency of immunization programs. Compared with standalone polio vaccines, combined polio vaccines not only serve the public health function of preventing poliomyelitis, but also represent the transition of pediatric vaccines from single-antigen products toward combination, premium, convenient, and systematic immunization management, making them a key reflection of a vaccine company?s technology platform, quality system, and market competitiveness.In 2025, global Combined polio vaccine production reached approximately 42 million units.The average gross profit margin of this product is 85%.
The market opportunities for combined polio vaccines come from immunization strategy upgrading in the post-oral live attenuated vaccine era, rising demand for more convenient pediatric vaccination, and the value release of premium combination vaccine platforms. As global polio eradication enters its late stage, immunization strategies containing IPV components are becoming increasingly important for safety, long-term protection, and sustainable supply. China has optimized its routine polio immunization schedule, reflecting the national immunization system?s recognition of the foundational role of inactivated polio vaccines. Combination vaccines further integrate polio protection with pediatric immunization needs such as diphtheria, tetanus, pertussis, and Hib, transforming the product from a single public health vaccine into a high-value pediatric immunization solution. For manufacturers, combined polio vaccines can extend product life cycles, strengthen brand barriers, and drive upgrades in registration, production, cold chain, terminal education, and international cooperation capabilities.
The biggest challenges in this industry lie in multi-antigen compatibility, clinical validation, quality consistency, and regulatory barriers. A combination vaccine is not simply the mixing of several antigens; it must balance antigen compatibility, adjuvant systems, stability, immune interference, batch consistency, and safety monitoring. IPV-containing combination vaccines also involve virus culture, inactivation validation, antigen quantification, and biosafety control, making production significantly more complex than ordinary monovalent vaccines. Because pediatric vaccines are administered to infants and young children, regulators, disease control systems, and parents have extremely high expectations for product quality, adverse event monitoring, supply stability, and brand credibility. At the same time, pricing systems, regional procurement cycles, competitive substitution, reimbursement environments, and changes in vaccination willingness may affect commercialization progress and profitability flexibility.
Downstream demand is evolving from ?completing scheduled vaccination? toward pediatric immunization management with fewer injections, higher efficiency, and better user experience. Disease control institutions and vaccination clinics hope that combination vaccines can reduce queuing pressure, lower missed-dose risk, simplify vaccination procedures, and improve service efficiency. Parents care more about reducing children?s pain, making vaccination schedules clearer, and choosing products with stronger safety credibility. Medical institutions and private vaccination sites place greater value on premium vaccine combinations, differentiated services, and brand recognition. As young families become more aware of preventive medicine, acceptance of combination vaccines is expected to continue improving. In the future, IPV-containing multivalent vaccines will gradually move from supplementary options in basic immunization toward an important direction for premium, convenient, and branded pediatric vaccination.
This report studies the global Combined Polio Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Combined Polio Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Combined Polio Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Combined Polio Vaccine total production and demand, 2021-2032, (K Units)
Global Combined Polio Vaccine total production value, 2021-2032, (USD Million)
Global Combined Polio Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Combined Polio Vaccine consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Combined Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Combined Polio Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Combined Polio Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Combined Polio Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Combined Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Viatris, Pfizer, Sanofi, BD, Eli Lilly, Gerresheimer, Dongbao, Ypsomed, Owen Mumford, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Combined Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Combined Polio Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Quadruple Vaccine
- Pentavalent Vaccine
- Other
- Vero Cell
- Human Diploid
- Primary Cell
- Recombinant
- National Immunization
- Pediatric Clinics
- CDC Procurement
- International Supply
- Novo Nordisk
- Viatris
- Pfizer
- Sanofi
- BD
- Eli Lilly
- Gerresheimer
- Dongbao
- Ypsomed
- Owen Mumford
- Antares Pharma
- Haselmeier
- West Pharmaceutical
1. How big is the global Combined Polio Vaccine market?
2. What is the demand of the global Combined Polio Vaccine market?
3. What is the year over year growth of the global Combined Polio Vaccine market?
4. What is the production and production value of the global Combined Polio Vaccine market?
5. Who are the key producers in the global Combined Polio Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Combined Polio Vaccine Introduction
1.2 World Combined Polio Vaccine Supply & Forecast
1.2.1 World Combined Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Combined Polio Vaccine Production (2021-2032)
1.2.3 World Combined Polio Vaccine Pricing Trends (2021-2032)
1.3 World Combined Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Combined Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Combined Polio Vaccine Production by Region (2021-2032)
1.3.3 World Combined Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Combined Polio Vaccine Production (2021-2032)
1.3.5 Europe Combined Polio Vaccine Production (2021-2032)
1.3.6 Japan Combined Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Combined Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Combined Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Combined Polio Vaccine Demand (2021-2032)
2.2 World Combined Polio Vaccine Consumption by Region
2.2.1 World Combined Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Combined Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Combined Polio Vaccine Consumption (2021-2032)
2.4 China Combined Polio Vaccine Consumption (2021-2032)
2.5 Europe Combined Polio Vaccine Consumption (2021-2032)
2.6 Japan Combined Polio Vaccine Consumption (2021-2032)
2.7 South Korea Combined Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Combined Polio Vaccine Consumption (2021-2032)
2.9 India Combined Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Combined Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Combined Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Combined Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Combined Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Combined Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Combined Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Combined Polio Vaccine in 2025
3.6 Combined Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Combined Polio Vaccine Market: Region Footprint
3.6.2 Combined Polio Vaccine Market: Company Product Type Footprint
3.6.3 Combined Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Combined Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Combined Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Combined Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Combined Polio Vaccine Production Comparison
4.2.1 United States VS China: Combined Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Combined Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Combined Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Combined Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Combined Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Combined Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Combined Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Combined Polio Vaccine Production (2021-2026)
4.5 China Based Combined Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Combined Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Combined Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Combined Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Combined Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Combined Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Combined Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Quadruple Vaccine
5.2.2 Pentavalent Vaccine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Combined Polio Vaccine Production by Type (2021-2032)
5.3.2 World Combined Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Combined Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MARKET CHANNEL
6.1 World Combined Polio Vaccine Market Size Overview by Market Channel: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Market Channel
6.2.1 Vero Cell
6.2.2 Human Diploid
6.2.3 Primary Cell
6.2.4 Recombinant
6.3 Market Segment by Market Channel
6.3.1 World Combined Polio Vaccine Production by Market Channel (2021-2032)
6.3.2 World Combined Polio Vaccine Production Value by Market Channel (2021-2032)
6.3.3 World Combined Polio Vaccine Average Price by Market Channel (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Combined Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 National Immunization
7.2.2 Pediatric Clinics
7.2.3 CDC Procurement
7.2.4 International Supply
7.3 Market Segment by Application
7.3.1 World Combined Polio Vaccine Production by Application (2021-2032)
7.3.2 World Combined Polio Vaccine Production Value by Application (2021-2032)
7.3.3 World Combined Polio Vaccine Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Novo Nordisk
8.1.1 Novo Nordisk Details
8.1.2 Novo Nordisk Major Business
8.1.3 Novo Nordisk Combined Polio Vaccine Product and Services
8.1.4 Novo Nordisk Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Novo Nordisk Recent Developments/Updates
8.1.6 Novo Nordisk Competitive Strengths & Weaknesses
8.2 Viatris
8.2.1 Viatris Details
8.2.2 Viatris Major Business
8.2.3 Viatris Combined Polio Vaccine Product and Services
8.2.4 Viatris Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Viatris Recent Developments/Updates
8.2.6 Viatris Competitive Strengths & Weaknesses
8.3 Pfizer
8.3.1 Pfizer Details
8.3.2 Pfizer Major Business
8.3.3 Pfizer Combined Polio Vaccine Product and Services
8.3.4 Pfizer Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Pfizer Recent Developments/Updates
8.3.6 Pfizer Competitive Strengths & Weaknesses
8.4 Sanofi
8.4.1 Sanofi Details
8.4.2 Sanofi Major Business
8.4.3 Sanofi Combined Polio Vaccine Product and Services
8.4.4 Sanofi Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Sanofi Recent Developments/Updates
8.4.6 Sanofi Competitive Strengths & Weaknesses
8.5 BD
8.5.1 BD Details
8.5.2 BD Major Business
8.5.3 BD Combined Polio Vaccine Product and Services
8.5.4 BD Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 BD Recent Developments/Updates
8.5.6 BD Competitive Strengths & Weaknesses
8.6 Eli Lilly
8.6.1 Eli Lilly Details
8.6.2 Eli Lilly Major Business
8.6.3 Eli Lilly Combined Polio Vaccine Product and Services
8.6.4 Eli Lilly Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Eli Lilly Recent Developments/Updates
8.6.6 Eli Lilly Competitive Strengths & Weaknesses
8.7 Gerresheimer
8.7.1 Gerresheimer Details
8.7.2 Gerresheimer Major Business
8.7.3 Gerresheimer Combined Polio Vaccine Product and Services
8.7.4 Gerresheimer Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Gerresheimer Recent Developments/Updates
8.7.6 Gerresheimer Competitive Strengths & Weaknesses
8.8 Dongbao
8.8.1 Dongbao Details
8.8.2 Dongbao Major Business
8.8.3 Dongbao Combined Polio Vaccine Product and Services
8.8.4 Dongbao Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Dongbao Recent Developments/Updates
8.8.6 Dongbao Competitive Strengths & Weaknesses
8.9 Ypsomed
8.9.1 Ypsomed Details
8.9.2 Ypsomed Major Business
8.9.3 Ypsomed Combined Polio Vaccine Product and Services
8.9.4 Ypsomed Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Ypsomed Recent Developments/Updates
8.9.6 Ypsomed Competitive Strengths & Weaknesses
8.10 Owen Mumford
8.10.1 Owen Mumford Details
8.10.2 Owen Mumford Major Business
8.10.3 Owen Mumford Combined Polio Vaccine Product and Services
8.10.4 Owen Mumford Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Owen Mumford Recent Developments/Updates
8.10.6 Owen Mumford Competitive Strengths & Weaknesses
8.11 Antares Pharma
8.11.1 Antares Pharma Details
8.11.2 Antares Pharma Major Business
8.11.3 Antares Pharma Combined Polio Vaccine Product and Services
8.11.4 Antares Pharma Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Antares Pharma Recent Developments/Updates
8.11.6 Antares Pharma Competitive Strengths & Weaknesses
8.12 Haselmeier
8.12.1 Haselmeier Details
8.12.2 Haselmeier Major Business
8.12.3 Haselmeier Combined Polio Vaccine Product and Services
8.12.4 Haselmeier Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Haselmeier Recent Developments/Updates
8.12.6 Haselmeier Competitive Strengths & Weaknesses
8.13 West Pharmaceutical
8.13.1 West Pharmaceutical Details
8.13.2 West Pharmaceutical Major Business
8.13.3 West Pharmaceutical Combined Polio Vaccine Product and Services
8.13.4 West Pharmaceutical Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 West Pharmaceutical Recent Developments/Updates
8.13.6 West Pharmaceutical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Combined Polio Vaccine Industry Chain
9.2 Combined Polio Vaccine Upstream Analysis
9.2.1 Combined Polio Vaccine Core Raw Materials
9.2.2 Main Manufacturers of Combined Polio Vaccine Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Combined Polio Vaccine Production Mode
9.6 Combined Polio Vaccine Procurement Model
9.7 Combined Polio Vaccine Industry Sales Model and Sales Channels
9.7.1 Combined Polio Vaccine Sales Model
9.7.2 Combined Polio Vaccine Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Combined Polio Vaccine Introduction
1.2 World Combined Polio Vaccine Supply & Forecast
1.2.1 World Combined Polio Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Combined Polio Vaccine Production (2021-2032)
1.2.3 World Combined Polio Vaccine Pricing Trends (2021-2032)
1.3 World Combined Polio Vaccine Production by Region (Based on Production Site)
1.3.1 World Combined Polio Vaccine Production Value by Region (2021-2032)
1.3.2 World Combined Polio Vaccine Production by Region (2021-2032)
1.3.3 World Combined Polio Vaccine Average Price by Region (2021-2032)
1.3.4 North America Combined Polio Vaccine Production (2021-2032)
1.3.5 Europe Combined Polio Vaccine Production (2021-2032)
1.3.6 Japan Combined Polio Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Combined Polio Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Combined Polio Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Combined Polio Vaccine Demand (2021-2032)
2.2 World Combined Polio Vaccine Consumption by Region
2.2.1 World Combined Polio Vaccine Consumption by Region (2021-2026)
2.2.2 World Combined Polio Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Combined Polio Vaccine Consumption (2021-2032)
2.4 China Combined Polio Vaccine Consumption (2021-2032)
2.5 Europe Combined Polio Vaccine Consumption (2021-2032)
2.6 Japan Combined Polio Vaccine Consumption (2021-2032)
2.7 South Korea Combined Polio Vaccine Consumption (2021-2032)
2.8 ASEAN Combined Polio Vaccine Consumption (2021-2032)
2.9 India Combined Polio Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Combined Polio Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Combined Polio Vaccine Production by Manufacturer (2021-2026)
3.3 World Combined Polio Vaccine Average Price by Manufacturer (2021-2026)
3.4 Combined Polio Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Combined Polio Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Combined Polio Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Combined Polio Vaccine in 2025
3.6 Combined Polio Vaccine Market: Overall Company Footprint Analysis
3.6.1 Combined Polio Vaccine Market: Region Footprint
3.6.2 Combined Polio Vaccine Market: Company Product Type Footprint
3.6.3 Combined Polio Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Combined Polio Vaccine Production Value Comparison
4.1.1 United States VS China: Combined Polio Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Combined Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Combined Polio Vaccine Production Comparison
4.2.1 United States VS China: Combined Polio Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Combined Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Combined Polio Vaccine Consumption Comparison
4.3.1 United States VS China: Combined Polio Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Combined Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Combined Polio Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Combined Polio Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Combined Polio Vaccine Production (2021-2026)
4.5 China Based Combined Polio Vaccine Manufacturers and Market Share
4.5.1 China Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Combined Polio Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Combined Polio Vaccine Production (2021-2026)
4.6 Rest of World Based Combined Polio Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Combined Polio Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Combined Polio Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Combined Polio Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Quadruple Vaccine
5.2.2 Pentavalent Vaccine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Combined Polio Vaccine Production by Type (2021-2032)
5.3.2 World Combined Polio Vaccine Production Value by Type (2021-2032)
5.3.3 World Combined Polio Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MARKET CHANNEL
6.1 World Combined Polio Vaccine Market Size Overview by Market Channel: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Market Channel
6.2.1 Vero Cell
6.2.2 Human Diploid
6.2.3 Primary Cell
6.2.4 Recombinant
6.3 Market Segment by Market Channel
6.3.1 World Combined Polio Vaccine Production by Market Channel (2021-2032)
6.3.2 World Combined Polio Vaccine Production Value by Market Channel (2021-2032)
6.3.3 World Combined Polio Vaccine Average Price by Market Channel (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Combined Polio Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 National Immunization
7.2.2 Pediatric Clinics
7.2.3 CDC Procurement
7.2.4 International Supply
7.3 Market Segment by Application
7.3.1 World Combined Polio Vaccine Production by Application (2021-2032)
7.3.2 World Combined Polio Vaccine Production Value by Application (2021-2032)
7.3.3 World Combined Polio Vaccine Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Novo Nordisk
8.1.1 Novo Nordisk Details
8.1.2 Novo Nordisk Major Business
8.1.3 Novo Nordisk Combined Polio Vaccine Product and Services
8.1.4 Novo Nordisk Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Novo Nordisk Recent Developments/Updates
8.1.6 Novo Nordisk Competitive Strengths & Weaknesses
8.2 Viatris
8.2.1 Viatris Details
8.2.2 Viatris Major Business
8.2.3 Viatris Combined Polio Vaccine Product and Services
8.2.4 Viatris Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Viatris Recent Developments/Updates
8.2.6 Viatris Competitive Strengths & Weaknesses
8.3 Pfizer
8.3.1 Pfizer Details
8.3.2 Pfizer Major Business
8.3.3 Pfizer Combined Polio Vaccine Product and Services
8.3.4 Pfizer Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Pfizer Recent Developments/Updates
8.3.6 Pfizer Competitive Strengths & Weaknesses
8.4 Sanofi
8.4.1 Sanofi Details
8.4.2 Sanofi Major Business
8.4.3 Sanofi Combined Polio Vaccine Product and Services
8.4.4 Sanofi Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Sanofi Recent Developments/Updates
8.4.6 Sanofi Competitive Strengths & Weaknesses
8.5 BD
8.5.1 BD Details
8.5.2 BD Major Business
8.5.3 BD Combined Polio Vaccine Product and Services
8.5.4 BD Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 BD Recent Developments/Updates
8.5.6 BD Competitive Strengths & Weaknesses
8.6 Eli Lilly
8.6.1 Eli Lilly Details
8.6.2 Eli Lilly Major Business
8.6.3 Eli Lilly Combined Polio Vaccine Product and Services
8.6.4 Eli Lilly Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Eli Lilly Recent Developments/Updates
8.6.6 Eli Lilly Competitive Strengths & Weaknesses
8.7 Gerresheimer
8.7.1 Gerresheimer Details
8.7.2 Gerresheimer Major Business
8.7.3 Gerresheimer Combined Polio Vaccine Product and Services
8.7.4 Gerresheimer Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Gerresheimer Recent Developments/Updates
8.7.6 Gerresheimer Competitive Strengths & Weaknesses
8.8 Dongbao
8.8.1 Dongbao Details
8.8.2 Dongbao Major Business
8.8.3 Dongbao Combined Polio Vaccine Product and Services
8.8.4 Dongbao Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 Dongbao Recent Developments/Updates
8.8.6 Dongbao Competitive Strengths & Weaknesses
8.9 Ypsomed
8.9.1 Ypsomed Details
8.9.2 Ypsomed Major Business
8.9.3 Ypsomed Combined Polio Vaccine Product and Services
8.9.4 Ypsomed Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Ypsomed Recent Developments/Updates
8.9.6 Ypsomed Competitive Strengths & Weaknesses
8.10 Owen Mumford
8.10.1 Owen Mumford Details
8.10.2 Owen Mumford Major Business
8.10.3 Owen Mumford Combined Polio Vaccine Product and Services
8.10.4 Owen Mumford Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Owen Mumford Recent Developments/Updates
8.10.6 Owen Mumford Competitive Strengths & Weaknesses
8.11 Antares Pharma
8.11.1 Antares Pharma Details
8.11.2 Antares Pharma Major Business
8.11.3 Antares Pharma Combined Polio Vaccine Product and Services
8.11.4 Antares Pharma Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.11.5 Antares Pharma Recent Developments/Updates
8.11.6 Antares Pharma Competitive Strengths & Weaknesses
8.12 Haselmeier
8.12.1 Haselmeier Details
8.12.2 Haselmeier Major Business
8.12.3 Haselmeier Combined Polio Vaccine Product and Services
8.12.4 Haselmeier Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.12.5 Haselmeier Recent Developments/Updates
8.12.6 Haselmeier Competitive Strengths & Weaknesses
8.13 West Pharmaceutical
8.13.1 West Pharmaceutical Details
8.13.2 West Pharmaceutical Major Business
8.13.3 West Pharmaceutical Combined Polio Vaccine Product and Services
8.13.4 West Pharmaceutical Combined Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.13.5 West Pharmaceutical Recent Developments/Updates
8.13.6 West Pharmaceutical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Combined Polio Vaccine Industry Chain
9.2 Combined Polio Vaccine Upstream Analysis
9.2.1 Combined Polio Vaccine Core Raw Materials
9.2.2 Main Manufacturers of Combined Polio Vaccine Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Combined Polio Vaccine Production Mode
9.6 Combined Polio Vaccine Procurement Model
9.7 Combined Polio Vaccine Industry Sales Model and Sales Channels
9.7.1 Combined Polio Vaccine Sales Model
9.7.2 Combined Polio Vaccine Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Combined Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Combined Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Combined Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Combined Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Combined Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Combined Polio Vaccine Production by Region (2021-2026) & (K Units)
Table 7. World Combined Polio Vaccine Production by Region (2027-2032) & (K Units)
Table 8. World Combined Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Combined Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Combined Polio Vaccine Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Combined Polio Vaccine Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Combined Polio Vaccine Major Market Trends
Table 13. World Combined Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Combined Polio Vaccine Consumption by Region (2021-2026) & (K Units)
Table 15. World Combined Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Combined Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Combined Polio Vaccine Producers in 2025
Table 18. World Combined Polio Vaccine Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Combined Polio Vaccine Producers in 2025
Table 20. World Combined Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Combined Polio Vaccine Company Evaluation Quadrant
Table 22. World Combined Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Combined Polio Vaccine Production Site of Key Manufacturer
Table 24. Combined Polio Vaccine Market: Company Product Type Footprint
Table 25. Combined Polio Vaccine Market: Company Product Application Footprint
Table 26. Combined Polio Vaccine Competitive Factors
Table 27. Combined Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Combined Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Combined Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Combined Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Combined Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Combined Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Combined Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Combined Polio Vaccine Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Combined Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Combined Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Combined Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Combined Polio Vaccine Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Combined Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Combined Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Combined Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Combined Polio Vaccine Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Combined Polio Vaccine Production Market Share (2021-2026)
Table 47. World Combined Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Combined Polio Vaccine Production by Type (2021-2026) & (K Units)
Table 49. World Combined Polio Vaccine Production by Type (2027-2032) & (K Units)
Table 50. World Combined Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Combined Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Combined Polio Vaccine Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Combined Polio Vaccine Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Combined Polio Vaccine Production Value by Market Channel, (USD Million), 2021 & 2025 & 2032
Table 55. World Combined Polio Vaccine Production by Market Channel (2021-2026) & (K Units)
Table 56. World Combined Polio Vaccine Production by Market Channel (2027-2032) & (K Units)
Table 57. World Combined Polio Vaccine Production Value by Market Channel (2021-2026) & (USD Million)
Table 58. World Combined Polio Vaccine Production Value by Market Channel (2027-2032) & (USD Million)
Table 59. World Combined Polio Vaccine Average Price by Market Channel (2021-2026) & (US$/Unit)
Table 60. World Combined Polio Vaccine Average Price by Market Channel (2027-2032) & (US$/Unit)
Table 61. World Combined Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Combined Polio Vaccine Production by Application (2021-2026) & (K Units)
Table 63. World Combined Polio Vaccine Production by Application (2027-2032) & (K Units)
Table 64. World Combined Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 65. World Combined Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 66. World Combined Polio Vaccine Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Combined Polio Vaccine Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 69. Novo Nordisk Major Business
Table 70. Novo Nordisk Combined Polio Vaccine Product and Services
Table 71. Novo Nordisk Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Novo Nordisk Recent Developments/Updates
Table 73. Novo Nordisk Competitive Strengths & Weaknesses
Table 74. Viatris Basic Information, Manufacturing Base and Competitors
Table 75. Viatris Major Business
Table 76. Viatris Combined Polio Vaccine Product and Services
Table 77. Viatris Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Viatris Recent Developments/Updates
Table 79. Viatris Competitive Strengths & Weaknesses
Table 80. Pfizer Basic Information, Manufacturing Base and Competitors
Table 81. Pfizer Major Business
Table 82. Pfizer Combined Polio Vaccine Product and Services
Table 83. Pfizer Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Pfizer Recent Developments/Updates
Table 85. Pfizer Competitive Strengths & Weaknesses
Table 86. Sanofi Basic Information, Manufacturing Base and Competitors
Table 87. Sanofi Major Business
Table 88. Sanofi Combined Polio Vaccine Product and Services
Table 89. Sanofi Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Sanofi Recent Developments/Updates
Table 91. Sanofi Competitive Strengths & Weaknesses
Table 92. BD Basic Information, Manufacturing Base and Competitors
Table 93. BD Major Business
Table 94. BD Combined Polio Vaccine Product and Services
Table 95. BD Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. BD Recent Developments/Updates
Table 97. BD Competitive Strengths & Weaknesses
Table 98. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 99. Eli Lilly Major Business
Table 100. Eli Lilly Combined Polio Vaccine Product and Services
Table 101. Eli Lilly Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Eli Lilly Recent Developments/Updates
Table 103. Eli Lilly Competitive Strengths & Weaknesses
Table 104. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 105. Gerresheimer Major Business
Table 106. Gerresheimer Combined Polio Vaccine Product and Services
Table 107. Gerresheimer Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Gerresheimer Recent Developments/Updates
Table 109. Gerresheimer Competitive Strengths & Weaknesses
Table 110. Dongbao Basic Information, Manufacturing Base and Competitors
Table 111. Dongbao Major Business
Table 112. Dongbao Combined Polio Vaccine Product and Services
Table 113. Dongbao Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Dongbao Recent Developments/Updates
Table 115. Dongbao Competitive Strengths & Weaknesses
Table 116. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 117. Ypsomed Major Business
Table 118. Ypsomed Combined Polio Vaccine Product and Services
Table 119. Ypsomed Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Ypsomed Recent Developments/Updates
Table 121. Ypsomed Competitive Strengths & Weaknesses
Table 122. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 123. Owen Mumford Major Business
Table 124. Owen Mumford Combined Polio Vaccine Product and Services
Table 125. Owen Mumford Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Owen Mumford Recent Developments/Updates
Table 127. Owen Mumford Competitive Strengths & Weaknesses
Table 128. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 129. Antares Pharma Major Business
Table 130. Antares Pharma Combined Polio Vaccine Product and Services
Table 131. Antares Pharma Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Antares Pharma Recent Developments/Updates
Table 133. Antares Pharma Competitive Strengths & Weaknesses
Table 134. Haselmeier Basic Information, Manufacturing Base and Competitors
Table 135. Haselmeier Major Business
Table 136. Haselmeier Combined Polio Vaccine Product and Services
Table 137. Haselmeier Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Haselmeier Recent Developments/Updates
Table 139. Haselmeier Competitive Strengths & Weaknesses
Table 140. West Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 141. West Pharmaceutical Major Business
Table 142. West Pharmaceutical Combined Polio Vaccine Product and Services
Table 143. West Pharmaceutical Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. West Pharmaceutical Recent Developments/Updates
Table 145. West Pharmaceutical Competitive Strengths & Weaknesses
Table 146. Global Key Players of Combined Polio Vaccine Upstream (Raw Materials)
Table 147. Global Combined Polio Vaccine Typical Customers
Table 148. Combined Polio Vaccine Typical Distributors
Table 1. World Combined Polio Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Combined Polio Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Combined Polio Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Combined Polio Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Combined Polio Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Combined Polio Vaccine Production by Region (2021-2026) & (K Units)
Table 7. World Combined Polio Vaccine Production by Region (2027-2032) & (K Units)
Table 8. World Combined Polio Vaccine Production Market Share by Region (2021-2026)
Table 9. World Combined Polio Vaccine Production Market Share by Region (2027-2032)
Table 10. World Combined Polio Vaccine Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Combined Polio Vaccine Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Combined Polio Vaccine Major Market Trends
Table 13. World Combined Polio Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Combined Polio Vaccine Consumption by Region (2021-2026) & (K Units)
Table 15. World Combined Polio Vaccine Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Combined Polio Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Combined Polio Vaccine Producers in 2025
Table 18. World Combined Polio Vaccine Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Combined Polio Vaccine Producers in 2025
Table 20. World Combined Polio Vaccine Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Combined Polio Vaccine Company Evaluation Quadrant
Table 22. World Combined Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Combined Polio Vaccine Production Site of Key Manufacturer
Table 24. Combined Polio Vaccine Market: Company Product Type Footprint
Table 25. Combined Polio Vaccine Market: Company Product Application Footprint
Table 26. Combined Polio Vaccine Competitive Factors
Table 27. Combined Polio Vaccine New Entrant and Capacity Expansion Plans
Table 28. Combined Polio Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Combined Polio Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Combined Polio Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Combined Polio Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Combined Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Combined Polio Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Combined Polio Vaccine Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Combined Polio Vaccine Production Market Share (2021-2026)
Table 37. China Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Combined Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Combined Polio Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Combined Polio Vaccine Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Combined Polio Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Combined Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Combined Polio Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Combined Polio Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Combined Polio Vaccine Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Combined Polio Vaccine Production Market Share (2021-2026)
Table 47. World Combined Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Combined Polio Vaccine Production by Type (2021-2026) & (K Units)
Table 49. World Combined Polio Vaccine Production by Type (2027-2032) & (K Units)
Table 50. World Combined Polio Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Combined Polio Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Combined Polio Vaccine Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Combined Polio Vaccine Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Combined Polio Vaccine Production Value by Market Channel, (USD Million), 2021 & 2025 & 2032
Table 55. World Combined Polio Vaccine Production by Market Channel (2021-2026) & (K Units)
Table 56. World Combined Polio Vaccine Production by Market Channel (2027-2032) & (K Units)
Table 57. World Combined Polio Vaccine Production Value by Market Channel (2021-2026) & (USD Million)
Table 58. World Combined Polio Vaccine Production Value by Market Channel (2027-2032) & (USD Million)
Table 59. World Combined Polio Vaccine Average Price by Market Channel (2021-2026) & (US$/Unit)
Table 60. World Combined Polio Vaccine Average Price by Market Channel (2027-2032) & (US$/Unit)
Table 61. World Combined Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Combined Polio Vaccine Production by Application (2021-2026) & (K Units)
Table 63. World Combined Polio Vaccine Production by Application (2027-2032) & (K Units)
Table 64. World Combined Polio Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 65. World Combined Polio Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 66. World Combined Polio Vaccine Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Combined Polio Vaccine Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 69. Novo Nordisk Major Business
Table 70. Novo Nordisk Combined Polio Vaccine Product and Services
Table 71. Novo Nordisk Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Novo Nordisk Recent Developments/Updates
Table 73. Novo Nordisk Competitive Strengths & Weaknesses
Table 74. Viatris Basic Information, Manufacturing Base and Competitors
Table 75. Viatris Major Business
Table 76. Viatris Combined Polio Vaccine Product and Services
Table 77. Viatris Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Viatris Recent Developments/Updates
Table 79. Viatris Competitive Strengths & Weaknesses
Table 80. Pfizer Basic Information, Manufacturing Base and Competitors
Table 81. Pfizer Major Business
Table 82. Pfizer Combined Polio Vaccine Product and Services
Table 83. Pfizer Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Pfizer Recent Developments/Updates
Table 85. Pfizer Competitive Strengths & Weaknesses
Table 86. Sanofi Basic Information, Manufacturing Base and Competitors
Table 87. Sanofi Major Business
Table 88. Sanofi Combined Polio Vaccine Product and Services
Table 89. Sanofi Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Sanofi Recent Developments/Updates
Table 91. Sanofi Competitive Strengths & Weaknesses
Table 92. BD Basic Information, Manufacturing Base and Competitors
Table 93. BD Major Business
Table 94. BD Combined Polio Vaccine Product and Services
Table 95. BD Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. BD Recent Developments/Updates
Table 97. BD Competitive Strengths & Weaknesses
Table 98. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 99. Eli Lilly Major Business
Table 100. Eli Lilly Combined Polio Vaccine Product and Services
Table 101. Eli Lilly Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Eli Lilly Recent Developments/Updates
Table 103. Eli Lilly Competitive Strengths & Weaknesses
Table 104. Gerresheimer Basic Information, Manufacturing Base and Competitors
Table 105. Gerresheimer Major Business
Table 106. Gerresheimer Combined Polio Vaccine Product and Services
Table 107. Gerresheimer Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Gerresheimer Recent Developments/Updates
Table 109. Gerresheimer Competitive Strengths & Weaknesses
Table 110. Dongbao Basic Information, Manufacturing Base and Competitors
Table 111. Dongbao Major Business
Table 112. Dongbao Combined Polio Vaccine Product and Services
Table 113. Dongbao Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Dongbao Recent Developments/Updates
Table 115. Dongbao Competitive Strengths & Weaknesses
Table 116. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 117. Ypsomed Major Business
Table 118. Ypsomed Combined Polio Vaccine Product and Services
Table 119. Ypsomed Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Ypsomed Recent Developments/Updates
Table 121. Ypsomed Competitive Strengths & Weaknesses
Table 122. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 123. Owen Mumford Major Business
Table 124. Owen Mumford Combined Polio Vaccine Product and Services
Table 125. Owen Mumford Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Owen Mumford Recent Developments/Updates
Table 127. Owen Mumford Competitive Strengths & Weaknesses
Table 128. Antares Pharma Basic Information, Manufacturing Base and Competitors
Table 129. Antares Pharma Major Business
Table 130. Antares Pharma Combined Polio Vaccine Product and Services
Table 131. Antares Pharma Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 132. Antares Pharma Recent Developments/Updates
Table 133. Antares Pharma Competitive Strengths & Weaknesses
Table 134. Haselmeier Basic Information, Manufacturing Base and Competitors
Table 135. Haselmeier Major Business
Table 136. Haselmeier Combined Polio Vaccine Product and Services
Table 137. Haselmeier Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 138. Haselmeier Recent Developments/Updates
Table 139. Haselmeier Competitive Strengths & Weaknesses
Table 140. West Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 141. West Pharmaceutical Major Business
Table 142. West Pharmaceutical Combined Polio Vaccine Product and Services
Table 143. West Pharmaceutical Combined Polio Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. West Pharmaceutical Recent Developments/Updates
Table 145. West Pharmaceutical Competitive Strengths & Weaknesses
Table 146. Global Key Players of Combined Polio Vaccine Upstream (Raw Materials)
Table 147. Global Combined Polio Vaccine Typical Customers
Table 148. Combined Polio Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Combined Polio Vaccine Picture
Figure 2. World Combined Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Combined Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 5. World Combined Polio Vaccine Average Price (2021-2032) & (US$/Unit)
Figure 6. World Combined Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Combined Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 9. Europe Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 10. Japan Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 11. Combined Polio Vaccine Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 14. World Combined Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 15. United States Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 16. China Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 17. Europe Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 18. Japan Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 19. South Korea Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 20. ASEAN Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 21. India Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of Combined Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Combined Polio Vaccine Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Combined Polio Vaccine Markets in 2025
Figure 25. United States VS China: Combined Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Combined Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Combined Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Combined Polio Vaccine Production Market Share 2025
Figure 29. China Based Manufacturers Combined Polio Vaccine Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Combined Polio Vaccine Production Market Share 2025
Figure 31. World Combined Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Combined Polio Vaccine Production Value Market Share by Type in 2025
Figure 33. Quadruple Vaccine
Figure 34. Pentavalent Vaccine
Figure 35. Other
Figure 36. World Combined Polio Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Combined Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Combined Polio Vaccine Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Combined Polio Vaccine Production Value by Market Channel, (USD Million), 2021 & 2025 & 2032
Figure 40. World Combined Polio Vaccine Production Value Market Share by Market Channel in 2025
Figure 41. Vero Cell
Figure 42. Human Diploid
Figure 43. Primary Cell
Figure 44. Recombinant
Figure 45. World Combined Polio Vaccine Production Market Share by Market Channel (2021-2032)
Figure 46. World Combined Polio Vaccine Production Value Market Share by Market Channel (2021-2032)
Figure 47. World Combined Polio Vaccine Average Price by Market Channel (2021-2032) & (US$/Unit)
Figure 48. Public Program
Figure 49. Private Market
Figure 50. Travel Vaccine
Figure 51. Stockpile
Figure 52. World Combined Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Combined Polio Vaccine Production Value Market Share by Application in 2025
Figure 54. National Immunization
Figure 55. Pediatric Clinics
Figure 56. CDC Procurement
Figure 57. International Supply
Figure 58. World Combined Polio Vaccine Production Market Share by Application (2021-2032)
Figure 59. World Combined Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 60. World Combined Polio Vaccine Average Price by Application (2021-2032) & (US$/Unit)
Figure 61. Combined Polio Vaccine Industry Chain
Figure 62. Combined Polio Vaccine Procurement Model
Figure 63. Combined Polio Vaccine Sales Model
Figure 64. Combined Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
Figure 1. Combined Polio Vaccine Picture
Figure 2. World Combined Polio Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Combined Polio Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 5. World Combined Polio Vaccine Average Price (2021-2032) & (US$/Unit)
Figure 6. World Combined Polio Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Combined Polio Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 9. Europe Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 10. Japan Combined Polio Vaccine Production (2021-2032) & (K Units)
Figure 11. Combined Polio Vaccine Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 14. World Combined Polio Vaccine Consumption Market Share by Region (2021-2032)
Figure 15. United States Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 16. China Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 17. Europe Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 18. Japan Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 19. South Korea Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 20. ASEAN Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 21. India Combined Polio Vaccine Consumption (2021-2032) & (K Units)
Figure 22. Producer Shipments of Combined Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Combined Polio Vaccine Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Combined Polio Vaccine Markets in 2025
Figure 25. United States VS China: Combined Polio Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Combined Polio Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Combined Polio Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Combined Polio Vaccine Production Market Share 2025
Figure 29. China Based Manufacturers Combined Polio Vaccine Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Combined Polio Vaccine Production Market Share 2025
Figure 31. World Combined Polio Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Combined Polio Vaccine Production Value Market Share by Type in 2025
Figure 33. Quadruple Vaccine
Figure 34. Pentavalent Vaccine
Figure 35. Other
Figure 36. World Combined Polio Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Combined Polio Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Combined Polio Vaccine Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Combined Polio Vaccine Production Value by Market Channel, (USD Million), 2021 & 2025 & 2032
Figure 40. World Combined Polio Vaccine Production Value Market Share by Market Channel in 2025
Figure 41. Vero Cell
Figure 42. Human Diploid
Figure 43. Primary Cell
Figure 44. Recombinant
Figure 45. World Combined Polio Vaccine Production Market Share by Market Channel (2021-2032)
Figure 46. World Combined Polio Vaccine Production Value Market Share by Market Channel (2021-2032)
Figure 47. World Combined Polio Vaccine Average Price by Market Channel (2021-2032) & (US$/Unit)
Figure 48. Public Program
Figure 49. Private Market
Figure 50. Travel Vaccine
Figure 51. Stockpile
Figure 52. World Combined Polio Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Combined Polio Vaccine Production Value Market Share by Application in 2025
Figure 54. National Immunization
Figure 55. Pediatric Clinics
Figure 56. CDC Procurement
Figure 57. International Supply
Figure 58. World Combined Polio Vaccine Production Market Share by Application (2021-2032)
Figure 59. World Combined Polio Vaccine Production Value Market Share by Application (2021-2032)
Figure 60. World Combined Polio Vaccine Average Price by Application (2021-2032) & (US$/Unit)
Figure 61. Combined Polio Vaccine Industry Chain
Figure 62. Combined Polio Vaccine Procurement Model
Figure 63. Combined Polio Vaccine Sales Model
Figure 64. Combined Polio Vaccine Sales Channels, Direct Sales, and Distribution
Figure 65. Methodology
Figure 66. Research Process and Data Source
